Article Text

Download PDFPDF
Patient-administered Sphenopalatine Ganglion Block
  1. Edouard Saade, M.D. and
  2. Glenn B. Paige, M.D.
  1. Department of Anesthesiology, University of Florida College of Medicine, Gainesville, Florida
  1. Reprint requests: Edouard Saade, M.D., Attn: Editorial Office, Department of Anesthesiology, University of Florida College of Medicine, P.O. Box 100254, Gainesville, FL 32610-0254.


Background and Objectives Pain resulting from head and neck cancer can be severe and difficult to manage. Avoiding hospitalization for as long as possible with a reasonable level of comfort requires a number of therapeutic modalities. The usefulness of self-administered sphenopalatine ganglion block was evaluated in a patient with lethal midline granuloma requiring large doses of morphine.

Methods A 30-year-old woman with intractable pain from lethal midline granuloma was taught to self-administer 4% lidocaine, 1.5 mL topically into each nostril three times per day.

Results A 3-month follow-up examination showed substantial pain relief and reduction in morphine requirement. No adverse side effects or complications developed.

Conclusions In certain patients, sphenopalatine ganglion block can be effectively self-administered at home to manage chronic pain.

  • cancer
  • lidocaine
  • pain
  • sphenopalatine ganglion block

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.